Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Who is the bag holder now???
Going to single digits
Never forget:
Linda Powers showed us the path forward how in the span of 18 months the company is moving from a clinal trial stage to a profitable high growth company!
Enjoy the ride!!
Very rotten indeed. Shareintel continues to collect data
Mark the close
Very good synopsis. If I were to come down with cancer if would pack my bags and head for the UK!
Since this trial is not sponsored by NWBO that can’t pr it
Ha ha ha!!
here were noticeable differences in median survival between the treatments groups for both OS (placebo: 7.7 months, poly-ICLC: 52.5 months, and resiquimod: 16.7 months; log-rank P?=?0.017) and PFS (placebo: 5.5 months, poly-ICLC: 31.4 months and resiquimod: 8.1 months;
Whoa!
Peer reviewed!
Insiders to sell shares in 30 days
Toxic financing for a company who’s price is down 90% in last 3 years
Today is the pump. Tomorrow is the insider dump
#dcvax $nwbo #gbm
— Peter Davis (@peter_brit) April 2, 2024
Washinton State's HCA has denied coverage for Tumor Treating Fields, preventing access to this treatment option for Washington Medicaid patients and state employees.
'Optune/Tumor Treating Fields (TTF):
Petition for rereview received. Not selected for… pic.twitter.com/OPPsTyjXhk
insider selling in 3...2...1...
"Preliminary analyses of key secondary endpoints (time to neurocognitive failure, overall survival, and radiological response rate) did not demonstrate statistical significance."
pump and dump in progress
Kate has cancer and people are here on this board bashing a proven treatment.
A double from this price??
Ya I could see that
Just saying:
"Defendants’ manipulative spoofing often occurred during periods when there was increasing investor enthusiasm concerning NWBO’s share price. Plaintiff examined posts concerning NWBO on the popular message board platform InvestorsHub. This message board is popular among investors in small-cap and over-the-counter stocks, including NWBO, and the U.S. Department of Justice and Securities and Exchange Commission have alleged that posts on InvestorsHub are material for OTC stocks."
Hey Shorty McFudster:
The legal eagles are watching you!!!
The fudsters have been doxxed!!!
Let’s get to discovery and expose them all!!
Collaborations. The Company continued active discussions on certain combination treatment regimens and is planning for certain strategic trials with such combination treatments. Some of these would be in connection with the Company’s in-licensing of intellectual property and others would be separate collaborations. The Company anticipates proceeding with such an initial combination during 2024 when it is able to free up sufficiently from the MAA review process and the inspections processes.
From todays 10-K
Fast track baby!
Now that we have cracked the code for cell mass production the value of this company just increased massively!!!
The King is pleased
An interesting picture in the article:
https://bnnbreaking.com/mental-health-crisis/health-updates-royal-familys-cancer-battle-and-global-health-developments
You have friends?
From the last 2 Qs:
The Company is in active discussions in regard to certain combination treatment regimens and is planning for certain strategic trials with such combination treatments.
Just sayin
Sure is nice that it has already been approved for compassionate use. The mhra knows what it’s looking at and won’t delay
They mentioned this timeframe in the pr:
https://www.gov.uk/guidance/marketing-authorisation-application-submission-dates-for-150-days-national-and-european-commission-decision-reliance-procedures
They made the December 25 deadline. March 22 approval at the latest
Desperation for sure
Northwest Bio files for mhra approval
https://www.prnewswire.com/news-releases/northwest-biotherapeutics-announces-that-a-marketing-authorization-application-has-been-submitted-to-the-uk-mhra-for-dcvax-l-for-glioblastoma-302021038.html
NVCR is toast!
Game changer!
Congratulations to all longs! The future looks incredibly bright!
If a cancer has gone metastatic would dvax direct be useful?
Speaking of losing their shirts. Nevercure’s earnings and future guidance is awful
Hopefully Dvax can be used in off label indications in the future until approval in other cancers
Ha ha ha!
This ship is sinking fast!
I see this loan as one of the final steps to applications to the four regulators
Regulators take cash - not shares!